Date: 2011-02-15
Type of information: Grant
Company: Newron Pharmaceuticals (Italy)
Investors: Ministero dell’ Istruzione, dell’ Università e della Ricerca (Italy)
Amount: €3.7 million
Funding type: grant
Planned used: The grant supports the research and identification of novel compounds for the treatment of diseases of the Central Nervous System.
Others: Newron Pharmaceuticals has been advised by the Italian government’s Ministero dell’ Istruzione, dell’ Università e della Ricerca, that it is to receive a total payment of € 3.7 million with immediate effect, as part of a € 5 million grant for innovative R&D. In 2008 Newron was awarded the € 5 million grant by the Ministry towards a € 5.3 million R&D program ongoing at the company. The grant supports the research and identification of novel compounds for the treatment of diseases of the Central Nervous System.
Therapeutic area: CNS diseases - Neurodegenerative diseases
